bispecific antibodies การใช้

In April 2009, the bispecific antibody catumaxomab was approved in the European Union.
Recently, the bispecific antibodies, a novel class of therapeutic antibodies, have yielded promising results in clinical trials.
Genentech was able to demonstrate in mouse models that the new bispecific antibody was able to reach therapeutic levels in the brain.
All of these formats can be composed from variable fragments with specificity for two different antigens, in which case they are types of bispecific antibodies.
In-vitro and in-vivo activity of CIK cells in conjunction with bispecific antibodies, cross-linking cytotoxic effector cells with malignant targets, was enhanced compared with CIK cells alone.